We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 44 start-ups with an aggregate funding of $143.5b. The average funding per company in this subset is $3.3b.
Last update to the database: Feb 18, 2025. See changelog.
2
Funding Rounds
$16.8m
Money raised
Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.
2
Funding Rounds
$11.3m
Money raised
Emergex aims to tackle the global threat of infectious disease by providing affordable and practical on-demand vaccine solutions.
7
Funding Rounds
$31.4m
Money raised
Oxford Genetics, also known as Oxgene, is a synthetic biology company specializing in DNA design, protein expression optimization and cell line development technologies and services.
1
Funding Rounds
$100.0m
Money raised
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.
2
Funding Rounds
$37.5m
Money raised
A biomedical company in United Kingdom that develops vaccines and vaccine development technology
2
Funding Rounds
$2.6m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
5
Funding Rounds
$2.5m
Money raised
Molecular Warehouse Ltd. is a Guildford-based molecular diagnostics company founded in 2015 by Kirill Alexandrov, Nikita Alexandrov and Siro Perez.
3
Funding Rounds
$49.0m
Money raised
AI-powered imaging biomarkers solutions provider for stroke and lung fibrosis.
1
Funding Rounds
Oxford Cancer Biomarkers is an Oxford-based biomarker company commercializing biomarker tests for colorectal cancer testing.
1
Funding Rounds
$909.2k
Money raised
University of Oxford spin-out company that develops and commercializes enzymatic process technologies.
7
Funding Rounds
$25.9m
Money raised
Oxford BioTherapeutics is a clinical-stage oncology company based in Oxford, UK, Morristown, and San Jose, USA. The company develops immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies.
2
Funding Rounds
$6.4m
Money raised
Laboratory robotics and automation company
5
Funding Rounds
$65.8m
Money raised
Theolytics Ltd is an oncolytic Adenovirus Therapies founded in 2017.
3
Funding Rounds
$16.6m
Money raised
Optellum is a medical diagnostics company founded by Vaclav Potesil, Timor Kadir, Jerome Declerck, Sir Mike Brady FRS FREng FMedSci and Lyndsey Pickup.
3
Funding Rounds
$66.0m
Money raised
Ultromics is an artificial Intelligence company founded in 2017 by Paul Leeson.
2
Funding Rounds
$26.0m
Money raised
Developer of VR powered cognitive treatments intended to deliver psychological treatments.
7
Funding Rounds
$14.1m
Money raised
Cytox Limited is a company founded in 2004 by Zsuzsanna Nagy.
1
Funding Rounds
$150.0m
Money raised
ONI is a Super-Resolution Microscopy founded in 2016.
4
Funding Rounds
$49.4m
Money raised
Ochre Bio is a biotechnology platform focused on rejuvenating transplant livers founded in 2019 by Jack O'Meara.
2
Funding Rounds
$160.0m
Money raised
Beckley Psytech is a psychedelic Compounds founded in 2019 by Lady Amanda Feilding.
1
Funding Rounds
$86.4m
Money raised
Nucleome Therapeutics technology uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to help deliver the next generation of genetically guided therapeutics.
1
Funding Rounds
$13.0m
Money raised
Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases.
3
Funding Rounds
$40.6m
Money raised
Osler Diagnostics is a biosensor and medical device company.
1
Funding Rounds
$36.0m
Money raised
Perspectum Diagnostics Ltd is an Oxford-based developer of diagnostic technologies for diagnosing patients with liver disease, diabetes, and cancer.
1
Funding Rounds
$23.5m
Money raised
Blue Earth Diagnostics Limited is an Oxford-based developer and supplier of molecular imaging agents.
1
Funding Rounds
$2.2m
Money raised
Developer of bio-photonics and artificial intelligence technology designed to stratify patients for clinical trials. The company's technology uses a non-invasive, portable, inexpensive system to screen for Alzheimer's and other neurodegenerative diseases.
1
Funding Rounds
Enesi Pharma Limited is a solid Dose Vaccine Delivery founded in 2017.
2
Funding Rounds
$142.0b
Money raised
Organ transportation technology developer.
2
Funding Rounds
$12.6m
Money raised
Oxford Vacmedix UK Limited is a cancer Vaccines founded in 2012 by Dr Shisong Jiang.
1
Funding Rounds
$8.0m
Money raised
Adaptix is an Oxford-based company developing radiology technologies.
2
Funding Rounds
$4.6m
Money raised
Scancell is a cancer vaccine founded in 1996 by Professor Lindy Durrant.
1
Funding Rounds
$11.0m
Money raised
Base Genomics is an Oxford-based medical diagnostics company developing early-stage cancer detection blood tests.
1
Funding Rounds
$76.5m
Money raised
Blue Earth Therapeutics is a developer of radiotherapeutics to treat cancer patients founded in 2021.
1
Funding Rounds
$3.1m
Money raised
Caristo Diagnostics has created AI-driven digital imaging technology predicts heart attacks years in advance of current heart disease prediction technologies.
1
Funding Rounds
$40.0m
Money raised
IntraBio is a small molecule for rare diseases founded in 2015.
2
Funding Rounds
$80.0m
Money raised
Developer of therapeutics for chronic autoimmune and inflammatory diseases.
1
Funding Rounds
$3.2m
Money raised
HydRegen Limited is a chemical manufacturing alternative manufacturer founded in 2020.
2
Funding Rounds
$21.5m
Money raised
Oxeco is a surface treatments for composites and engineering plastics founded in 2005.
2
Funding Rounds
$99.0m
Money raised
Small molecules to increase tumor detection by the immune system.
1
Funding Rounds
$3.5m
Money raised
Platform for instant pathogen tests utilizing super-resolution microscopy and machine learning.
1
Funding Rounds
$16.0m
Money raised
Developer of vaccines for the treatment of cancer.
1
Funding Rounds
$8.8m
Money raised
Pathios Therapeutics Limited is a company founded in 2017.
1
Funding Rounds
$5.0m
Money raised
Mitochondrial-protective therapeutics developer to treat degenerative diseases.
1
Funding Rounds
$12.0m
Money raised
OMass Technologies is a clinical-stage drug discovery company founded in 2016.
Enter your email and get access to 71,000 + technology companies you can partner with.